These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6122905)

  • 21. Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
    Brockelman CR; Tan-Ariya P
    Am J Trop Med Hyg; 1982 Sep; 31(5):913-8. PubMed ID: 6751112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K
    Lancet; 1986 Jan; 1(8473):154. PubMed ID: 2867368
    [No Abstract]   [Full Text] [Related]  

  • 23. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
    Eastham GM; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1983; 77(1):91-3. PubMed ID: 6344364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polyresistance of asiatic P. falciparum to chloroquine and pyrimethamine-sulfadoxine combination. Apropos of a new case].
    Pays JF; Hugues FC
    Bull Soc Pathol Exot Filiales; 1981; 74(4):406-13. PubMed ID: 7028296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro sensitivity of Plasmodium falciparum to sulfadoxine and pyrimethamine.
    Klinkaewnarong W; Chongsuphajaisiddhi T; Sabchareon A; Brockelman CR
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):296-301. PubMed ID: 3906921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.
    Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Meemanee B; Wernsdorfer W
    Bull World Health Organ; 1987; 65(3):345-52. PubMed ID: 3311437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand.
    Hurwitz ES; Johnson D; Campbell CC
    Lancet; 1981 May; 1(8229):1068-70. PubMed ID: 6112445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
    Hess U; Timmermans PM; Jones M
    Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
    Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
    Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania.
    Hedman P; Rombo L; Björkman A; Brohult J; Kihamia CM; Potter J; Stenbeck J
    Ann Trop Med Parasitol; 1986 Feb; 80(1):7-11. PubMed ID: 3524485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination.
    Petersen E
    Trans R Soc Trop Med Hyg; 1987; 81(2):238-41. PubMed ID: 3303480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
    Tan-Ariya P; Brockelman CR; Menabandhu C
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.
    Chulay JD; Watkins WM; Sixsmith DG
    Am J Trop Med Hyg; 1984 May; 33(3):325-30. PubMed ID: 6375404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.
    Nguyen-Dinh P; Payne D; Teklehaimanot A; Zevallos-Ipenza A; Day MM; Duverseau YT
    Bull World Health Organ; 1985; 63(3):585-92. PubMed ID: 3899394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
    Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
    Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
    Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
    Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of a case of P. falciparum malaria resistant to chloroquine and combination of sulfalene and pyrimethamine in Delhi.
    Choudhury DS; Sinha S; Ghosh SK; Devi CU; Sharma VP
    Indian J Malariol; 1987 Jun; 24(1):95-6. PubMed ID: 3326756
    [No Abstract]   [Full Text] [Related]  

  • 40. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.